Quick Heal Technologies Limited reports 15% revenue growth during 9M FY19

• Revenue grew YoY by 15% to Rs. 2,289 million
• EBITDA grew YoY by 63% to Rs. 893 million with a Margin of 39%
• PAT grew YoY by 89% to Rs. 641 million with an improvement in Margin to 28%

PUNE, February 13, 2019: Quick Heal Technologies Limited (“Quick Heal”), India’s leading provider of IT Security Software Products and Solutions to individuals, businesses and Government, reported its reviewed and un-audited results for the quarter and nine month ending 31st December 2018.

Consolidated Financial Highlights:

Segmental Performance for the nine month ended 31 st December 2018

• Retail segment revenue up 15% to Rs. 1,924 million as compared to Rs. 1,680 million in the corresponding period of the previous year
  • Contributes 80% to Total Revenue

• Enterprise and Government segment revenue up 7% to Rs. 490 million as compared to Rs. 456 million in the corresponding period previous year
  • Contributes 20% to Total Revenue

Mr. Kailash Katkar, Managing Director & Chief Executive Officer, Quick Heal Technologies Limited, said; “There has been a sustained momentum in the business with an overall revenue growth of 15% in our YTD operating performance. During the year, we made conscious efforts to offer highly customised endpoint security, network security and data protection solutions to our enterprise customers and enhance engagement with the channel ecosystem. While retail segment grew by 15%, the growth of 7% in the Enterprise and Government segment has been lower than our expectations. However, we are confident that our leadership position backed by world-class products & solutions and deep intelligence on the threat landscape will enable us to deliver steady performance in the coming future.”

Mr. Nitin Kulkarni, Chief Financial Officer, Quick Heal Technologies Limited, added “Our unrelenting efforts to grow the business have started yielding results. For 9MFY19, we have witnessed a 15% growth in revenue which has been complemented by increase in EBITDA and PAT margins by 1,150 bps and 1,104 bps respectively. As of December 2018, overall working capital days stood at 77 days as compared to 83 days in March 2018.”

Mr. Vijay Mhaskar, Chief Operating Officer, Quick Heal Technologies Limited, commented “Our customers recognise and appreciate the superior protection, timely updates and cross-product integration delivered by our solutions. Our thrust on new innovations using artificial intelligence and machine learning will help us further strengthen our portfolio and keep us ahead of the curve in providing solutions to tackle the evolving cyber threat landscape. We continue to remain optimistic on the growth prospects in retail as well as enterprise & government segment in the coming future.”

Awards & Accreditations:

• Seqrite received best cybersecurity brand award at the ‘National Summit for Digital Innovation & Cybersecurity’

About Quick Heal Technologies Limited

Quick Heal Technologies Limited is one of the leading providers of IT security software products and solutions to individuals, businesses and Government. Incorporated in 1995 with a registered office in Pune, Quick Heal has a network of over 25,000 channel partners as on 31st December 2018. It conducts sales and marketing activities across India.

Quick Heal’s portfolio includes solutions under the widely recognized brand names ‘Quick Heal’ and ‘Seqrite’ across various operating systems and devices.

For more information about the Company, please visit our website www.quickheal.co.in

Safe Harbor Statement

This document may contain forward-looking statements about Quick Heal Technologies Limited, which are based on the beliefs, opinions, and expectations of the company’s management as the date of this press release and the companies do not assume any obligation to update their forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict. Consequently, readers should not place any undue reliance on such forward-looking statements.

For further details please contact